Recombinant Human Insulin API

Recombinant Human Insulin API is a high-purity biological active pharmaceutical ingredient produced using recombinant DNA technology. It is chemically identical to endogenous human insulin and is widely used in the formulation of injectable insulin products for the treatment of diabetes mellitus. The API meets pharmacopeial standards (USP/EP/IP) and is suitable for use in both short-acting and long-acting insulin formulations. Manufactured under GMP-compliant conditions, it ensures consistent quality, safety, and efficacy.